Synta Pharmaceuticals Corp. (NASDAQ:SNTA)

downgrade sign

Seven Stocks That Analysts Want You to Sell

This past week marked the fifth anniversary of the bottom of the market from March 2009. To celebrate those massive gains since then, the Dow Jones Industrial Average has now ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: AIG, GM, Rite Aid, Synta, Disney and More

Stocks are still very close to all-time highs, and investors want to avoid getting caught in the next sell-off while still participating in the market gains. 24/7 Wall St. reviews ...
Read Full Story »
research

Four Biotech Stocks Called to Double

The biotech market has been on fire this year, and there is every indication that things will continue. With huge binary events right around the corner, and many of the ...
Read Full Story »
$5

Eight Biotech Stocks Trading Near $5 With Huge Upside Potential

Often when a strong sell-off hits the stock market, the first stocks to go are the big momentum stocks that hedge funds often chase for performance and alpha. Right behind ...
Read Full Story »
buy sell

Ten Top Wall Street Analyst Stocks to Buy Trading Just Above or Below $5

Every quarter we like to review the research at the top firms we cover and look for any new stocks to buy that are priced either slightly above or under ...
Read Full Story »
biotech

Biotech Stocks Under $10 With Huge Upside Potential for 2014

Large cap biotech stocks have seen incredible stock performance over the past few years. The problem for many investors is that many of the key stocks have become so expensive ...
Read Full Story »
biotech

Jefferies Top Biotech Stocks to Buy

The world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not change all that much, the manner in which it can ...
Read Full Story »
health care

Top Stocks That May Move Big at Jefferies Global Healthcare Conference

Once again, the Wall Street conference calendar is heating up. Next week is the widely attended Jefferies Global Healthcare Conference in New York City. Following the success of last year’s ...
Read Full Story »
Stock Split Image

Nine More Secondary Offerings Coming to the Market (ANAD, CERS, OFC, DCTH, ETFC, SSNC, SNTA, SLCA, VIPS)

As the stock market keeps rising, investors have to expect that the wave of companies raising cash and insiders selling shares will only continue. We tracked a whopping 10 offerings ...
Read Full Story »

Today’s Market Winners and Losers

The stock market is up Friday on plans for the European Union plans to directly lend to targeted banks. The Dow Jones Industrial Average is up 1.66%, the S&P 500 is up 1.80% and the ...
Read Full Story »

Friday Turned Into Biotech Friday, Many Massive Movers On News

How many big movers can you see in one day in the biotech sector?  This is what investors should be asking.  If you didn't know better you might think there ...
Read Full Story »

Top Analyst Upgrades & Downgrades (ABMD, MT, BXP, DPZ, DRYS, FET, GPS, BLOX, LYB, OAK, POOL, SNTA, TSLA, URBN, WPI, ZIP)

These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Tuesday. ABIOMED Inc. (NASDAQ: ABMD) Cut to Neutral at Lazard Capital. ArcelorMittal (NYSE: ...
Read Full Story »

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments.  The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) ...
Read Full Story »

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend.   This is broken down ...
Read Full Story »

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

We are just about to get the first round of abstracts from companies presenting data at this year's American Society of Clinical Oncology meeting for 2009.  At BioHealthInvestor.com we compiled ...
Read Full Story »